more_vertIn 1981, a group of 17 macaques known as the Silver Spring Monkeys became the most famous research animals in the USA when Alex Pacheco, an undercover college student and animal rights activist, infiltrated the laboratory of psychologist Edward Taub to expose the experiments that took place inside. In his research on neuroplasticity, Taub severed the afferent ganglia to certain limbs while immobilising the limbs that were neurologically intact in an attempt to train the macaques to use the appendages that lacked neural feedback.
Preference: Plastic Surgery
903
Terry White Chemists branded children’s paracetamol syrup for 1 to 5 years and children’s paracetamol syrup for 6 to 12 years
Recall – risk of plastic fragments breaking from bottle and being ingested
Apohealth children’s paracetamol for 1 to 5 years, children’s paracetamol for 6 to 12 years, and children’s ibuprofen for 6 months to 12 years
Recall – risk of plastic fragments breaking from bottle and being ingested
[Perspectives] John Meara: helping to make surgery truly global
As Plastic Surgeon-in-Chief at Boston Children’s Hospital, John Meara often feels like he is running a small business. “With nine surgeons and 60 staff in the department, which is a major referral centre in the northeast of the United States, I’m kept pretty busy”, he says. These commitments make it all the more remarkable that Meara has spent considerable time in the past 2 years as one of the key figures behind the Lancet Commission on Global Surgery.
[Case Report Comment] Leukaemic vasculitis from myelodysplastic syndrome in context
Myelodysplastic syndrome (MDS) is a heterogeneous group of clonal stem cell disorders characterised by ineffective haemopoiesis with dysplastic features and the potential to progress to acute leukaemia. Systemic or immune manifestations have been reported in up to 10% of patients and are more frequent in patients with chronic myelomonocytic leukaemia, an overlap disease of MDS and chronic myeloproliferative neoplasms. Autoimmune disorders that accompany MDS include vasculitis, seronegative polyarthritis, neutrophilic dermatosis, inflammatory serous effusions, autoimmune cytopenias, and the presence of cryoglobulins.
Pharmacy Care children's paracetamol suspension for 6 to 12 years and Pharmacy Care children's paracetamol elixir for 1 to 5 years
Recall – risk of plastic fragments breaking from bottle and being ingested
Terry White Chemists branded ibuprofen children's suspension
Recall – risk of plastic fragments breaking from bottle and being ingested
Chemmart and Pharmacy Choice ibuprofen children's suspensions and Chemmart Children's Paracetamol 6 – 12 Years Concentrated
Recall – risk of plastic fragments breaking from bottle and being ingested
Your AMA Federal Council at work
What AMA Federal Councillors and other AMA members have been doing to advance your interests in the past month:
Name |
Position on Council |
Activity/Meeting |
Date |
|
A/Prof Brian Owler |
AMA President |
Meeting with Australian Health Practitioner Regulation Agency (AHPRA) and the Medical Board of Australia |
5/3/2015 |
|
Meeting with Royal Australasian College of Surgeons and Australian Plastic Surgery Association Presidents |
4/3/2015 |
||
|
Dr Brian Morton |
AMA Chair of General Practice |
GP Roundtable |
8/4/2015 |
|
UGPA |
25/03/2015 |
||
|
GP Roundtable |
17/3/2015 |
||
|
Dr Stephen Parnis |
AMA Vice President |
Meeting with Australian Health Practitioner Regulation Agency (AHPRA) and the Medical Board of Australia (MBA) on improving practitioner experience with notifications |
5/3/2015 |
|
Dr Andrew Miller |
AMA Federal Council Representative for Dermatologists |
PBS Authority medicines review reference group |
13/4/2015
|
|
MSAC (Medical Services Advisory Committee) Review Working Group for Skin Services |
20/2/2015 |
||
|
Dr Antonio Di Dio |
AMA Member |
Meeting with Australian Health Practitioner Regulation Agency (AHPRA) and the Medical Board of Australia (MBA) on improving practitioner experience with notifications |
5/3/2015 |
|
Dr Roderick McRae |
AMA Federal Councillor – Salaried Doctors |
Meeting with Australian Health Practitioner Regulation Agency (AHPRA) and the Medical Board of Australia (MBA) on improving practitioner experience with notifications |
5/3/2015 |
|
Dr Susan Neuhaus |
AMA Federal Councillor – Surgeons |
Meeting with Australian Health Practitioner Regulation Agency (AHPRA) and the Medical Board of Australia (MBA) on improving practitioner experience with notifications |
5/3/2015 |
|
Dr Robyn Langham |
AMA Federal Councillor – Victoria nominee and Chair of AMA Medical Practice Committee |
Australian Health Practitioner Regulation Agency’s (AHPRA) Prescribing Working Group (PWG) |
5/3/2015 |
|
Dr David Rivett |
AMA Federal Councillor |
IHPA Small Rural Hospitals Working Group |
5/2/2015 |
|
Dr Chris Moy |
AMA Federal Councillor |
PCEHR Safe Use Guides consultation (KPMG/ACSQHC) |
11/3/2015 |
|
NeHTA (National E-Health Transition Authority) Clinical Usability Program (CUP) Steering Group |
19/2/2015 |
||
|
Dr Richard Kidd |
AMA Federal Councillor |
PCEHR Safe Use Guides consultation (KPMG/ACSQHC) |
10/3/2015
|
|
Gateway Advisory Group |
9/2/2015
|
Your AMA Federal Council at work – 7 April 2015
What AMA Federal Councillors and other AMA members have been doing to advance your interests in the past month:
Name |
Position on Council |
Activity/Meeting |
Date |
|
A/Prof Brian Owler |
AMA President |
Meeting with Australian Health Practitioner Regulation Agency (AHPRA) and the Medical Board of Australia |
5/3/2015 |
|
Meeting with Royal Australasian College of Surgeons and Australian Plastic Surgery Association Presidents |
4/3/2015 |
||
|
Dr Brian Morton |
AMA Chair of General Practice |
GP Roundtable |
17/3/2015 |
|
Dr Stephen Parnis |
AMA Vice President |
Meeting with Australian Health Practitioner Regulation Agency (AHPRA) and the Medical Board of Australia (MBA) on improving practitioner experience with notifications |
5/3/2015 |
|
Dr Andrew Miller |
AMA Federal Council Representative for Dermatologists |
MSAC (Medical Services Advisory Committee) Review Working Group for Skin Services |
20/2/2015
|
|
Dr Antonio Di Dio |
AMA Member |
Meeting with Australian Health Practitioner Regulation Agency (AHPRA) and the Medical Board of Australia (MBA) on improving practitioner experience with notifications |
5/3/2015 |
|
Dr Roderick McRae |
AMA Federal Councillor – Salaried Doctors |
Meeting with Australian Health Practitioner Regulation Agency (AHPRA) and the Medical Board of Australia (MBA) on improving practitioner experience with notifications |
5/3/2015 |
|
Dr Susan Neuhaus |
AMA Federal Councillor – Surgeons |
Meeting with Australian Health Practitioner Regulation Agency (AHPRA) and the Medical Board of Australia (MBA) on improving practitioner experience with notifications |
5/3/2015 |
|
Dr Robyn Langham |
AMA Federal Councillor – Victoria nominee and Chair of AMA Medical Practice Committee |
Australian Health Practitioner Regulation Agency’s (AHPRA) Prescribing Working Group (PWG) |
5/3/2015 |
|
Dr David Rivett |
AMA Federal Councillor |
IHPA Small Rural Hospitals Working Group |
5/2/2015 |
|
Dr Chris Moy |
AMA Federal Councillor |
PCEHR Safe Use Guides consultation (KPMG/ACSQHC) |
11/3/2015 |
|
NeHTA (National E-Health Transition Authority) Clinical Usability Program (CUP) Steering Group |
19/2/2015 |
||
|
Dr Richard Kidd |
AMA Federal Councillor |
PCEHR Safe Use Guides consultation (KPMG/ACSQHC) |
10/3/2015
|
|
Gateway Advisory Group |
9/2/2015
|